BAKER DOUGLAS P 4
4 · OptimizeRx Corp · Filed Sep 2, 2021
Insider Transaction Report
Form 4
OptimizeRx CorpOPRX
BAKER DOUGLAS P
Chief Financial Officer
Transactions
- Sale
Common Stock (pursuant to 10B5-1 plan)
2021-08-31$66.62/sh−4,000$266,480→ 50,796 total
Footnotes (1)
- [F1]These shares sold pursuant to a plan of disposition adopted on May 11, 2021 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.